Iguana Healthcare Management as of Sept. 30, 2016
Portfolio Holdings for Iguana Healthcare Management
Iguana Healthcare Management holds 74 positions in its portfolio as reported in the September 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ultragenyx Pharmaceutical (RARE) | 5.0 | $14M | 200k | 70.94 | |
Biogen Idec (BIIB) | 5.0 | $14M | 45k | 313.02 | |
Shire | 4.5 | $13M | 65k | 193.86 | |
Clovis Oncology | 4.2 | $12M | 325k | 36.05 | |
Zimmer Holdings (ZBH) | 3.9 | $11M | 85k | 130.02 | |
Alexion Pharmaceuticals | 3.3 | $9.2M | 75k | 122.55 | |
Amgen (AMGN) | 3.3 | $9.2M | 55k | 166.82 | |
Gw Pharmaceuticals Plc ads | 3.1 | $8.6M | 65k | 132.72 | |
Pfizer (PFE) | 3.0 | $8.5M | 250k | 33.87 | |
Oncomed Pharmaceuticals | 3.0 | $8.3M | 725k | 11.43 | |
Celgene Corporation | 2.8 | $7.8M | 75k | 104.53 | |
Celgene Corp option | 2.8 | $7.8M | 75k | 104.52 | |
Medicines Company | 2.7 | $7.5M | 200k | 37.74 | |
Global Blood Therapeutics In | 2.7 | $7.5M | 325k | 23.05 | |
NuVasive | 2.4 | $6.7M | 100k | 66.66 | |
Aerie Pharmaceuticals | 2.2 | $6.2M | 165k | 37.74 | |
Mazor Robotics Ltd. equities | 1.8 | $5.2M | 200k | 25.87 | |
Alnylam Pharmaceuticals (ALNY) | 1.8 | $5.1M | 75k | 67.77 | |
Dermira | 1.8 | $5.1M | 150k | 33.82 | |
Gilead Sciences (GILD) | 1.7 | $4.7M | 60k | 79.12 | |
Merck & Co (MRK) | 1.7 | $4.7M | 75k | 62.41 | |
Glaukos (GKOS) | 1.6 | $4.5M | 120k | 37.74 | |
Exelixis (EXEL) | 1.6 | $4.5M | 350k | 12.79 | |
Healthways | 1.6 | $4.4M | 165k | 26.46 | |
Supernus Pharmaceuticals (SUPN) | 1.3 | $3.7M | 150k | 24.73 | |
Bristol Myers Squibb (BMY) | 1.2 | $3.5M | 65k | 53.92 | |
Merus N V (MRUS) | 1.2 | $3.4M | 200k | 16.75 | |
Gw Pharmaceuticals Plc ads | 1.2 | $3.3M | 25k | 132.72 | |
Cigna Corp | 1.2 | $3.3M | 25k | 130.32 | |
Minerva Neurosciences | 1.1 | $3.2M | 225k | 14.12 | |
Anthem (ELV) | 1.1 | $3.1M | 25k | 125.32 | |
Allscripts Healthcare Solutions (MDRX) | 1.1 | $3.0M | 225k | 13.17 | |
K2m Group Holdings | 1.0 | $2.9M | 165k | 17.78 | |
Spectranetics Corporation | 1.0 | $2.8M | 110k | 25.09 | |
Gw Pharmaceuticals Plc ads | 0.9 | $2.7M | 20k | 132.75 | |
Pacira Pharmaceuticals (PCRX) | 0.9 | $2.6M | 75k | 34.23 | |
Flamel Technologies | 0.9 | $2.5M | 200k | 12.40 | |
Alder Biopharmaceuticals | 0.9 | $2.5M | 75k | 32.77 | |
Aerie Pharmaceuticals Inc put | 0.9 | $2.5M | 65k | 37.74 | |
LHC | 0.8 | $2.4M | 65k | 36.88 | |
Impax Laboratories | 0.8 | $2.4M | 100k | 23.70 | |
Retrophin | 0.8 | $2.2M | 100k | 22.38 | |
BioScrip | 0.8 | $2.2M | 750k | 2.89 | |
PharMerica Corporation | 0.8 | $2.1M | 75k | 28.07 | |
Accelr8 Technology | 0.7 | $2.0M | 75k | 27.27 | |
Ionis Pharmaceuticals (IONS) | 0.7 | $1.8M | 50k | 36.64 | |
Acadia Healthcare (ACHC) | 0.6 | $1.7M | 35k | 49.54 | |
Kite Pharma | 0.6 | $1.7M | 30k | 55.87 | |
Ophthotech | 0.6 | $1.6M | 35k | 46.14 | |
Sarepta Therapeutics (SRPT) | 0.6 | $1.5M | 25k | 61.40 | |
Spark Therapeutics | 0.5 | $1.5M | 25k | 60.08 | |
Intersect Ent | 0.5 | $1.4M | 90k | 15.84 | |
Pharmerica Corp cmn | 0.5 | $1.4M | 50k | 28.08 | |
Tandem Diabetes Care | 0.5 | $1.4M | 185k | 7.66 | |
Invuity | 0.5 | $1.4M | 100k | 13.72 | |
Array BioPharma | 0.5 | $1.4M | 200k | 6.75 | |
Pacific Biosciences of California (PACB) | 0.5 | $1.3M | 150k | 8.96 | |
Five Prime Therapeutics Inc put | 0.5 | $1.3M | 25k | 52.00 | |
Acceleron Pharma | 0.5 | $1.3M | 35k | 36.20 | |
Macrogenics (MGNX) | 0.4 | $1.2M | 40k | 29.90 | |
Boston Scientific Corporation (BSX) | 0.4 | $1.2M | 50k | 23.80 | |
Gilead Sciences Inc option | 0.4 | $1.2M | 15k | 79.13 | |
Tenet Healthcare Corporation (THC) | 0.4 | $1.1M | 50k | 22.66 | |
Adma Biologics (ADMA) | 0.4 | $1.1M | 150k | 7.24 | |
Adaptimmune Therapeutics (ADAP) | 0.4 | $1.1M | 150k | 7.05 | |
Immunomedics | 0.3 | $975k | 300k | 3.25 | |
Chemocentryx | 0.3 | $906k | 150k | 6.04 | |
Pra Health Sciences | 0.3 | $848k | 15k | 56.53 | |
ACADIA Pharmaceuticals (ACAD) | 0.3 | $795k | 25k | 31.80 | |
Epizyme | 0.3 | $738k | 75k | 9.84 | |
Esperion Therapeutics Inc Ne | 0.2 | $693k | 50k | 13.86 | |
Esperion Therapeutics (ESPR) | 0.2 | $554k | 40k | 13.85 | |
Mei Pharma | 0.2 | $528k | 300k | 1.76 | |
Scynexis | 0.2 | $484k | 125k | 3.87 |